Welcome to our new COO, Hasse Herlevsen

To further strengthen our expertise within the Quality Control field, Hasse Herlevsen (former Corp. VP Quality, LEO Pharma) will join our team as COO.

Hasse will be responsible for the daily operation including all internal/external QC related projects. In addition he will also lead our membership in the NIST - Genome Editing Consortium and advise customers about standards and guidelines within the CRISPR Medicine field.

Sign-Up COBO-Q Newsletter and receive the latest updates within Quality Control Genome Editing.